This panel has a higher diagnostic performance than AFP in distinguishing HCC from high-risk cirrhosis populations, with the area under the receiver-operating characteristic curve (ROC) of 0.807 for the panel versus 0.650 for AFP in the validation set. This evidence concerns the gene AFP and Cirrhosis.